Schmidt, Jonas
Berghaus, Sandro
Blessing, Frithjof
Wenzel, Folker
Herbeck, Holger
Blessing, Josef
Schierack, Peter
Rödiger, Stefan
Roggenbuck, Dirk
Funding for this research was provided by:
Brandenburgische TU Cottbus-Senftenberg
Article History
Received: 23 June 2021
Accepted: 12 October 2021
First Online: 1 November 2021
Competing interests
: DR holds an executive position and is a shareholder in Medipan and GA Generic Assays, which are diagnostic manufacturers. FB is the managing director of the Institute for Laboratory Medicine. JS, SB and HH are employees of this institution. The remaining authors declare no potential conflict of interest.